[Remote] Senior Vice President, Clinical Development Oncology (Remote)

Note: The job is a remote job and is open to candidates in USA. Elevar Therapeutics is a rapidly growing biotech company focused on oncology. They are seeking a strategic and hands-on Senior Vice President, Clinical Development Oncology to lead the clinical advancement of their oncology pipeline, overseeing clinical development strategy and regulatory engagement.ResponsibilitiesLead the overall clinical development strategy for oncology programs with primary focus on cholangiocarcinoma and hepatocellular carcinoma from early development through late-stage and registration-enabling studiesDevelop and execute integrated clinical development plans aligned with regulatory objectives including study protocol design, execution, and data analysis/interpretation, in conjunction with other relevant functional leadersDirect study design, protocol development, and execution for Phase 1-3 clinical trials, including pivotal registrational cancer studiesProvide expert oversight of clinical data analysis and interpretation, ensuring data are robust, clinically meaningful, and suitable to support regulatory decision-makingContribute to pipeline strategy and diligence for new internal and external oncology opportunities, providing senior clinical and regulatory development inputServe as a clinical development lead for global regulatory interactions, working in close partnership with Regulatory Affairs to define strategy and messagingLead and actively participate in meetings with regulatory agencies (e.g., FDA, EMA, MHRA), including scientific advice, End-of-Phase, pre-NDA/BLA, and ad hoc regulatory interactions, from a clinical development perspectiveProvide senior clinical oversight and direction for the review of NDA and/or BLA clinical components, including clinical summaries, integrated analyses, and supporting study documentationLead the clinical development contribution to responses to health authority questions, including written responses to information requests, major review questions, and post-submission clarificationsEnsure that clinical strategy, trial design, and data presentation are aligned with evolving regulatory guidance and agency feedback throughout the product lifecycleEnsure the quality, consistency, and regulatory readiness of all clinical documents, including Investigators’ Brochures, protocols, CSRs, safety narratives, and submission-critical documentsProvide senior scientific and clinical input into study-related documentation, including ICFs, CRFs, SAPs, clinical pharmacology analysis plans, and data interpretation narrativesSkills10-15+ years of clinical development experience in biotech or pharmaceutical industry, with a strong focus in oncologyDemonstrated experience in late-stage development and regulatory submission support, including clinical leadership for NDA and/or BLA filings and responses to health authority feedbackProven ability to lead regulatory interactions from a clinical development perspective and translate agency feedback into actionable development plansDeep understanding of GCP, ICH, FDA, and global regulatory requirements, oncology trial design, and interpretation of complex clinical datasetsStrong track record of building and leading multidisciplinary clinical teams and influencing cross-functionallyDemonstrated commitment to ethics, patient safety, and scientific rigor, with ability to represent the company credibly in internal and external settingsAbility to prioritize effectively and perform in a fast-paced, remote, and rapidly evolving environment with a hands-on, 'get-it-done' mindsetAbility to demonstrate Elevar's core values by holding ourselves and each other accountable for the work we do, taking time to collaborate effectively while working remotely, making space for ingenuity in work and thought, and staying grounded in compassion with a commitment to putting patients firstMD strongly preferred; advanced scientific degree (PhD, PharmD) considered with substantial relevant clinical development experienceDirect experience in liver cancers (HCC, cholangiocarcinoma) strongly preferredExperience in start-up or emerging biotech setting preferredExperience operating successfully in a start-up or emerging biotech environment strongly preferredBenefitsMedicalDentalVisionTime offA retirement planOther voluntary benefits for employeesCompany OverviewElevar Therapeutics specializes in clinical development of promising therapies for unmet medical needs in cancer. It was founded in 2005, and is headquartered in Salt Lake City, Utah, USA, with a workforce of 11-50 employees. Its website is https://elevartherapeutics.com.